Anxiety in men on active surveillance for early prostate cancer and their partners
Part of Cancer, Kidney & urinary, Mental health clinical trials.
This study looks at anxiety levels in men who have chosen active surveillance for early prostate cancer, as well as in their partners or significant others. It aims to understand how this approach affects emotional well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You started active surveillance for localized prostate cancer between 2007 and 2023.
- You receive your prostate cancer care at Lille University Hospital's Urology Department.
- You have a life partner or someone you share your daily life with.
- You can speak and understand French.
- You agree to take part in the study and have signed the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well “active surveillance” works for men with prostate cancer who are considered higher risk because of family history or genetics. It aims to safely monitor the cancer and decide the best timing for treatment if needed, while tracking side effects and follow-up success.
This study follows people with newly diagnosed prostate cancer to understand care decisions and outcomes over the long term. It uses routine medical information and asks you to complete questionnaires, which may help improve future treatment and support.
This study tests a decision aid to help men aged 65 and older with early-stage prostate cancer decide whether to choose active surveillance (monitoring the cancer instead of immediate treatment). The goal is to see if the tool helps men and their care partners make a more informed choice.
This trial follows men with prostate cancer who choose “active surveillance” instead of immediate treatment. It tests whether careful tracking (including patient reports) can help manage cancer over time and guide decision-making.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
This trial studies a “watchful waiting” approach, where doctors closely monitor certain prostate cancers with regular checkups and repeat biopsies. It may help people avoid or delay treatment side effects while watching for signs the cancer needs treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.